about
Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond EffectivenessThe Role of Health-Related Quality of Life Data in the Drug Approval Processes in the US and EuropeThe US Biosimilars ActThe Value of Patient-Centred Registries in Phase IV Drug SurveillancePortfolio Decisions in Early DevelopmentChallenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer.Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine.Electronic Diaries: Appraisal and Current Status.New Financial and Research Models for Pediatric Orphan Drug Development - Focus on the NCATS TRND ProgramThe Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore.Do Molecular Structures of Migraine Drugs Point to a Common Cause of this Elusive Disease and Suggest Future Drug Designs?Global Access Programs: A Collaborative Approach for Effective Implementation and Management.Advances in Gene Delivery Systems.Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore.Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder.Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making.A Method for Retrieval of Adverse Event Terms in Clinical Trial Databases Using Standardised MedDRA Queries.Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions.Measuring and Improving Physician Knowledge of Safety Risks Using Traditional and Online Methods in Pharmacovigilance.Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter Medications.Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?Medicines Regulation in Africa: Current State and Opportunities.Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey.Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks.International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain.Drugs in Clinical Development for MelanomaDefining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.Evaluation of Two Strategies for Community-Based Safety Monitoring during Seasonal Malaria Chemoprevention Campaigns in Senegal, Compared with the National Spontaneous Reporting System.Stem Cell-Based Toxicity ScreeningEU Compassionate Use Programmes (CUPs)Drug Development in Schizophrenia: Summary and TableStandardizing the Benefit-Risk Assessment of New MedicinesAchieving Ethnic Diversity in Trial RecruitmentPharmacovigilance Regulatory Requirements in Latin AmericaAn Investigation of Disagreement in Causality Assessment of Adverse Drug ReactionsExtracting Knowledge from Failed Development ProgrammesRepurposing Strategies for TherapeuticsChina as a Growing Research Base for Innovation in Medicines Development
P1433
Q27693421-49079CE4-1F43-4B82-A55C-C584BB7F1BEAQ29013209-84744C0C-D3EA-4C35-8ADB-D9C6DDCCCEBCQ29039936-AEEC3413-DFE1-44F3-87DF-DFBC55019DD9Q29395899-AF156E14-04F7-4817-8BA0-D66BBE4579DAQ29999056-71237B6E-189C-4D05-A330-A7BFB2A48683Q30490454-F4BDEDB8-3A5D-4FBD-8B88-35C6D20C157EQ30933660-6941A1DC-2CE0-4025-BB28-E55A4DFDCFFCQ33551958-B5FE1B55-C8B7-4713-BAD6-01A4ECB02DCAQ33621814-DAB2C2B9-5411-4A2D-B410-C1D1067B5C41Q33676582-3C042ACA-4CDE-4403-AFCF-33796727786BQ35119436-4A9BE900-79E8-4765-8984-DBB6AD263C65Q35349879-7B2A9CAD-1C9D-401E-B27A-CCC255FEB459Q35632772-E92A8228-76C9-4929-AC78-061C08FCACDBQ36309300-DEC2D9AE-938F-4F53-B4E8-BB4EC0ADB407Q36480077-D5A02C4A-3926-4BEF-8728-5349B82139AFQ36755913-64EB48AA-AA67-41CA-B357-1B6E560C5A29Q37733456-6921AE7E-786B-4C88-B2E1-B65DAA709AB5Q38616891-31C6C841-77E7-47CF-B430-8A0444B4F105Q39701633-C7BBBDAE-A594-4A2B-8E36-4A2C5DD7ACC3Q41204304-8F6910A2-F2B9-433B-951D-F1201A1FCCDCQ41204320-04410A5E-C1B5-422C-B768-447E02CD83D7Q42032807-E12B7876-72E7-43AC-8BC2-5BF918A75F07Q42953078-1ABBE630-6C27-4B52-A09A-037F384539A6Q47142232-3E822AC6-5901-47D4-B77E-9E44506774E2Q47161547-6654340D-020B-42A3-A88B-33995D410D85Q47161890-2990389E-BDC4-410F-84C8-B246D6D26EEAQ49885272-C8E34A38-F7C7-4C4B-B547-58EBA174BD1BQ54264040-12231C03-0CD0-4976-8E2C-F12DB4F3DA1BQ55409997-D4FA0989-6729-4C6A-9549-64E6C5345EDBQ55410478-1647CA7A-5374-4ABA-B8C7-AE8C53D4F1A1Q55885235-D3C9E7C9-10B9-42AD-AFC5-CFD804F8D6CCQ55892527-3BFF3AA6-1996-4FE4-8BC7-713FD6B74B23Q55921085-6511CF21-13B7-4096-B408-FD68398B3B3BQ55934009-29F9AA41-BA81-4CDC-8C16-6A18D2434EBDQ56209497-D118440A-3BF3-4D3D-92BB-B2CF43848D64Q56483557-AFAAD4F2-795F-4A03-8601-586316E7E770Q56484509-5E3F3F9C-0A3C-44BA-AB06-BF6484FCBA54Q56535381-78281F15-71F5-45AA-B09F-FD5281F1532DQ56659239-8692BF35-0555-4ECF-8D70-2FD133AC1BCAQ56912254-367FDB8E-5DA4-4661-92D0-1A29919EEBCF
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Pharmaceutical Medicine
@ast
Pharmaceutical Medicine
@da
Pharmaceutical Medicine
@en
Pharmaceutical Medicine
@es
Pharmaceutical Medicine
@fi
Pharmaceutical Medicine
@fr
Pharmaceutical Medicine
@it
Pharmaceutical Medicine
@nb
Pharmaceutical Medicine
@nl
Pharmaceutical Medicine
@nn
type
label
Pharmaceutical Medicine
@ast
Pharmaceutical Medicine
@da
Pharmaceutical Medicine
@en
Pharmaceutical Medicine
@es
Pharmaceutical Medicine
@fi
Pharmaceutical Medicine
@fr
Pharmaceutical Medicine
@it
Pharmaceutical Medicine
@nb
Pharmaceutical Medicine
@nl
Pharmaceutical Medicine
@nn
prefLabel
Pharmaceutical Medicine
@ast
Pharmaceutical Medicine
@da
Pharmaceutical Medicine
@en
Pharmaceutical Medicine
@es
Pharmaceutical Medicine
@fi
Pharmaceutical Medicine
@fr
Pharmaceutical Medicine
@it
Pharmaceutical Medicine
@nb
Pharmaceutical Medicine
@nl
Pharmaceutical Medicine
@nn
P236
P1055
P1058
P1156
P1277
P1476
Pharmaceutical Medicine
@en